Publication | Open Access

A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer

OncologyMedicineMetronomic TherapyPathologyBronchial NeoplasmPharmacotherapyCarboplatin Versus EtoposideCancer TreatmentPharmacologyRadiation OncologyCarboplatin TreatmentLung Cancer